Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03409718 · ClinicalTrials.gov registry record
Database Retrieval for the Comprehensive Shoulder
A clinical trial of Rheumatoid Arthritis and Avascular Necrosis, sponsored by Zimmer Biomet.
- Active
- Registry status
- 160
- Enrollment target
- 1
- Study location
NCT03409718 is a study of Rheumatoid Arthritis and Avascular Necrosis that is active but no longer recruiting, run by Zimmer Biomet. The registered enrollment target is 160 participants, below the 4,690-participant average among 197 other Rheumatoid Arthritis trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state.
The verdict
NCT03409718, a study of Rheumatoid Arthritis and Avascular Necrosis, is active but no longer recruiting, sponsored by Zimmer Biomet.
- ACTIVE NOT RECRUITING
- Registry status
- 160 participants
- Enrollment target
- 1
- Study location
Study Summary
This study is a retrieval of database information regarding survivorship of the Comprehensive Shoulder System family of products. The primary objective of the retrieval is to collect data that will contribute to the post market surveillance requirements for this product and will provide feedback to design engineers, support marketing efforts and publications, and answer potential questions form reimbursement agencies.
Conditions Studied
Interventions
- DEVICE Biomet Comprehensive Shoulder System
Study Locations (1)
Maryland
- Acromion LLC - Towson
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 160 participants |
| Start Date | 2011-02-24 |
| Est. Completion | 2026-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03409718
The ClinicalTrials.gov registry entry for NCT03409718 describes a study currently listed as active not recruiting, categorized as an unspecified phase. The registered enrollment target is 160 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 4,690-participant average among 197 other Rheumatoid Arthritis trials with a reported enrollment target (97% lower). The listed sponsor is Zimmer Biomet, which has 115 total studies on file at ClinicalTrials.gov.
The record links to 7 conditions, with Rheumatoid Arthritis appearing as the primary indexed condition, and to 1 intervention - of which Biomet Comprehensive Shoulder System is the first listed.
NCT03409718 reports 1 study location spanning 1 distinct geographic area - top geographies include Maryland.
Frequently Asked Questions
What is clinical trial NCT03409718 about?
NCT03409718 is a clinical study titled "Database Retrieval for the Comprehensive Shoulder". This study is a retrieval of database information regarding survivorship of the Comprehensive Shoulder System family of products. The primary objective of the retrieval is to collect data that will contribute to the post market surveillance requirements for this product and will provide feedback to ...
What is the current status of trial NCT03409718?
This trial is currently active not recruiting. The enrollment target is 160 participants. The study started on 2011-02-24. Estimated completion is 2026-12.
What conditions does trial NCT03409718 study?
This clinical trial studies the following conditions: Rheumatoid Arthritis, Avascular Necrosis, Osteoarthritis of the Shoulder, Correction of Functional Deformity, Cuff Tear Arthropathy.
What interventions are being tested in trial NCT03409718?
The interventions under investigation include: Biomet Comprehensive Shoulder System (DEVICE).
Who is sponsoring clinical trial NCT03409718?
This trial is sponsored by Zimmer Biomet, which has 115 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03409718 being conducted?
This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Rheumatoid Arthritis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Rheumatology Diet Study
RECRUITING
-
Nivolumab in Treating Patients With Autoimmune Disorders and Advanced, Metastatic, or Unresectable Cancer
RECRUITING · Phase 1
-
EMPHASYS Cup Positioning in THA With Non-Invasive Navigation (Velys Hip Navigation (VHN))
RECRUITING · NA
-
Creating Health Course Study for People With Rheumatological Conditions
RECRUITING · NA
-
Physica System Total Knee Replacement Registry Study
RECRUITING · NA
-
Study of GS-0151 in Participants With Rheumatoid Arthritis
RECRUITING · Phase 1
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.